“seattle-genetics” Archives

in
Entry Author Date Location
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Cepheid, Propelled By Seattle Chemists, Sells to Danaher for $4B 09/06/16 San Francisco
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector & More 09/18/15 San Francisco
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus 06/11/15 Seattle
IPO “On the Horizon” for Unum After $65M Series B, CEO Says 06/11/15 Boston
Seattle Genetics Pays $25M to Buy Into Unum’s Souped-Up T-Cell Therapy 06/08/15 Boston
Join Us May 6 at the Hutch to Discuss Seattle Biotech’s Wild Ride 04/14/15 Seattle
ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs 03/23/15 Boston
Aura Bio Gets $21M, Pivots to Rare Eye Cancers With Virus Nanotech 03/05/15 Boston
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
With $21M, Retooled Blend Whips up Mini-Smart Bombs For Cancer 01/07/15 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More 09/12/14 Seattle
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Seattle Genetics Secures $9,000,000 New Financing Round 01/21/14 Seattle
Page 1 of 10 next page »